Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Need for symptomatic management in advanced multiple sclerosis.
Claudin-11 Tight Junctions in Myelin Are a Barrier to Diffusion and Lack Strong Adhesive Properties.
An Approach to Enhance Alignment and Myelination of Dorsal Root Ganglion Neurons.
Neurologic complications of immune checkpoint inhibitors.
Multiple sclerosis: experimental models and reality.
Glycyrrhizic acid prevents astrocyte death by neuromyelitis optica-specific IgG via inhibition of C1q binding.
Cyclin-dependent kinase inhibitor flavopiridol promotes remyelination in a cuprizone induced demyelination model.
Treatment of Orbital Complications Following Acute Rhinosinusitis in Children.
Static Posturography and Falls According to Pyramidal, Sensory and Cerebellar Functional Systems in People with Multiple Sclerosis.
Impaired function of C-nociceptors in chronic inflammatory demyelinating polyradiculopathy indicated by electrically induced axon flare reflex.
Cortical gray and subcortical white matter associations in Parkinson's disease.
[A treatment of neuromyelitis optica (Devic's disease) during pregnancy].
Alemtuzumab in the treatment of multiple sclerosis: patient selection and special considerations.
Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study.
An Energy Minimization Method for MS Lesion Segmentation From T1-w and FLAIR Images.
Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop.
Movement-to-music (m2m) As An Alternative Form Of Exercise Rehabilitation For An Individual With Multiple Sclerosis: 1568 Board #221 June 2, 8: 00 AM - 9: 30 AM.
If they are OK, we are OK: the experience of partners living with neuromyelitis optica.
Multiple sclerosis: Rapid diagnosis or right diagnosis?
Risk factors in multiple sclerosis: a population-based case-control study in Sicily. Background and methods.
Liver X receptors: from cholesterol regulation to neuroprotection-a new barrier against neurodegeneration in amyotrophic lateral sclerosis?
Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis.
Cognitive screening in Multiple Sclerosis: the Five-Point Test as a substitute for the PASAT in measuring executive function.
Osmotic Demyelination Syndrome Presenting with Chorea.
Get glammed up.
Pages
« first
‹ previous
…
776
777
778
779
780
781
782
783
784
…
next ›
last »